US EditionSNS saved over 292 million in six years with biosimilar drugs
Summary by Publico
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
SNS saved over 292 million in six years with biosimilar drugs
At stake are generics of biological drugs that are used to treat various diseases such as cancer and autoimmune diseases. The access to more information and the existence of rules by entities of the Ministry of Health can lead to an increase in its use, concludes a study by the National School of Public Health.
·Portugal
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
